Biospace: Errant Escalates Complaints to Lawsuit Over bluebird bio’s Gene Therapy
The ongoing battle between bluebird bio and tiny Errant Gene Therapeutics has escalated into a full-blown patent lawsuit, with Chicago-based Errant alleging that bluebird’s LentiGlobin and Zynteglo gene therapies infringe on patents for recombinant vectors they own.
View the rest of the article here
+1 (312) 441-1800
San Rocco Therapeutics
308 E. Emily St.
Tampa, FL 33603